Abstract
Alterations in the composition of the gut microbiota (dysbiosis) are observed in nutritional liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) and have been shown to be associated with the severity of both. Editing the composition of the microbiota by fecal microbiota transfer or by application of probiotics or prebiotics/fiber in rodent models and human proof-of-concept trials of NAFLD and ALD have demonstrated its possible contribution to reducing the progression of liver damage. In this review, we address the role of a soluble fiber, pectin, in reducing the development of liver injury in NAFLD and ALD through its impact on gut bacteria.
Subject
Food Science,Nutrition and Dietetics
Reference123 articles.
1. Therapeutic Landscape for NAFLD in 2020;Gastroenterology,2020
2. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review;Singal;JAMA,2021
3. Mechanisms of NAFLD development and therapeutic strategies;Friedman;Nat. Med.,2018
4. Alcoholic liver disease: Mechanisms of injury and targeted treatment;Louvet;Nat. Rev. Gastroenterol. Hepatol.,2015
5. Eslam1, M., Newsome, P.N., Sarin, S.K., Anstee, Q.M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wong, V.W., Dufour, J., and Schattenberg, J.M. (2020). A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol., 73, 202–209.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献